These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55. Long-term follow-up of pulmonary hypertension in patients with and without anorectic drug intake. Loogen F; Worth H; Schwan G; Goeckenjan G; Lösse B; Horstkotte D Cor Vasa; 1985; 27(2-3):111-24. PubMed ID: 4028729 [TBL] [Abstract][Full Text] [Related]
56. [Definitions and diagnosis of pulmonary hypertension]. Hoeper MM; Bogaard HJ; Condliffe R; Frantz R; Khanna D; Kurzyna M; Langleben D; Manes A; Satoh T; Torres F; Wilkins MR; Badesch DB Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 1():55-66. PubMed ID: 25697034 [TBL] [Abstract][Full Text] [Related]
57. A review of pulmonary arterial hypertension: role of ambrisentan. Barst RJ Vasc Health Risk Manag; 2007; 3(1):11-22. PubMed ID: 17583171 [TBL] [Abstract][Full Text] [Related]
58. [Pulmonary hypertension: definition, diagnostic and new classification]. Seferian A; Simonneau G Presse Med; 2014 Sep; 43(9):935-44. PubMed ID: 25127985 [TBL] [Abstract][Full Text] [Related]
59. Hemodynamics in pulmonary arterial hypertension: current and future perspectives. Saggar R; Sitbon O Am J Cardiol; 2012 Sep; 110(6 Suppl):9S-15S. PubMed ID: 22921033 [TBL] [Abstract][Full Text] [Related]
60. Review of the Ongoing Story of Appetite Suppressants, Serotonin Pathway, and Pulmonary Vascular Disease. Bazan IS; Fares WH Am J Cardiol; 2016 May; 117(10):1691-1696. PubMed ID: 27018933 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]